Skip to main content

Advertisement

Log in

Definition of AML susceptibility and classification using monoclonal antibodies

  • Published:
Medical Oncology and Tumor Pharmacotherapy Aims and scope Submit manuscript

Abstract

Of 112 patients with acute leukemia 13 exhibited terminal deoxyribonucleotidyl transferase activity (TdT) with a cell phenotype characterized by the presence of early or mature monocyte differentiation antigens detected by monoclonal antibodies and elevated serum lysozyme. These cells were either unclassifiable by cytochemical analysis or fell into the M2 or M5 categories by the French-American-British classification. These leukemias appear to form a distinct nosologic entity representing a malignant transformation among early cells in the monocyte lineage.

Among 60 patients with acute myelogenous leukemia 87% expressed the polymorphic Ia antigen detected by monoclonal antibody 109d6 compared to an incidence of 40.5% in the control population, relative risk 9.2. Evidence was obtained that this antigen was present in healthy family members and remission B-cells and monocytes of patients, and that its presence was associated with a genetically defined susceptibility state for the development of acute myelogenous leukemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bennett J M, Catovsky D, Daniel M T, Flandren D A, Galton H R, Gralnick H D, Sultan C: Proposals for the classification of acute leukemia.Br J Haemat 33, 451 (1976).

    Article  CAS  Google Scholar 

  2. Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity.Nature 256, 495 (1975).

    Article  PubMed  CAS  Google Scholar 

  3. Ugolina V, Nunez G, Smith G, Stastny P, Capra J D: Initial characterization of monoclonal antibodies against human monocytes.Proc Natn Acad Sci USA 77, 6564 (1980).

    Google Scholar 

  4. Bread J, Reinhertz E, Kung P C, Goldstein G, Schlossman S: A monoclonal antibody reactive with human peripheral blood monocytes.J Immun 124, 1943 (1980).

    Google Scholar 

  5. Eisenbarth G, Haynes B, Schroer J A, Fauci A S: Production of monoclonal antibodies reactive with peripheral blood mononuclear cell differentiation antigens.J Immun 124, 1237 (1980).

    PubMed  CAS  Google Scholar 

  6. Todd R F, Nadler L M, Schlossman S: Antigens on human monocytes identified by monoclonal antibodies.J Immun 126, 1435 (1980).

    Google Scholar 

  7. Dimitriu-Bona A, Burmester G R, Waters S W, Winchester R: Human mononuclear phagocyte differentiation-antigens.J Immun 130, 145 (1983).

    PubMed  CAS  Google Scholar 

  8. Dimitriu-Bona A, Kelley K, Winchester R: Differentiation antigens on human monocytes and monocyte-like U937 cells as defined by monoclonal antibodies.Fedn Proc Fedn Am Socs Exp Biol 41, 368 (1982).

    Google Scholar 

  9. Dimitriu-Bona A, Winchester R, Szer I, Reilly M, Najfeld V, Cuttner J: Expression of early or mature monocyte related antigens on certain acute myeloid leukemias.Clin Res 30, 512A (1982).

    Google Scholar 

  10. McGraw T P, Folds J D, Bollum F J, Stass S A: Terminal transferase positive acute myeloblastic leukemia.Am J Haemat 10, 251 (1981).

    Article  CAS  Google Scholar 

  11. Bettelheim P, Piaetta O, Majdic H, Gadner H, Schwartzmeir J, Knapp W: Expression of a myeloid marker on TdT positive acute lymphocytic leukemia cells: evidence by double fluorescence staining.Blood 60, 1392 (1982).

    PubMed  CAS  Google Scholar 

  12. Nunez-Roldan A, Szer I, Toguchi T, Cuttner J, Winchester R J: Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia: recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series.J Exp Med 156, 1872 (1982).

    Article  PubMed  CAS  Google Scholar 

  13. Toguchi T, Burmester G, Nunez-Roldan A, Gregersen P, Seremetis S, Lee S, Szer I, Hurley C, Winchester R: Evidence for the separate molecular expression of four distinct polymorphic Ia epitopes on cells of DR4 homozygous individuals.Human Immun (in press).

  14. Cuttner J, Seremetis S, Najfeld V, Dimitriu-Bona A, Winchester R J: TdT-positive acute leukemia with monocytoid characteristics: cytochemical, cytogenetic and immunological findings.Blood 64, 237 (1984).

    PubMed  CAS  Google Scholar 

  15. Seremetis S, Cuttner J, Winchester R J: Association of susceptibility to acute myelogenous leukemia (AML) with a non-DR Ia allodeterminant.Clin Res (abstract) (in press).

  16. Winchester R, Wang C V, Halper J, Hoffman T: Studies with B-cell allo- and hetero-antisera: parallel reactivity and special properties.Scand J Immun 5, 745 (1976).

    Article  CAS  Google Scholar 

  17. Winchester R J, Ross G D, Jarowski C I, Wang C Y, Halper J, Broxmeyer H E: Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation.Proc Natn Acad Sci USA 74, 4012 (1977).

    Article  CAS  Google Scholar 

  18. Goyert S M, Moriuchi J, Winchester R J, Silver J: HLA-DS molecules and their relation to supertypic specificities.Human Immun 8, 53 (1983).

    Article  CAS  Google Scholar 

  19. Navarette C, Festenstein H: In Knapp W (ed):Leukemia Markers (1983).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seremetis, S., Cuttner, J. & Winchester, R. Definition of AML susceptibility and classification using monoclonal antibodies. Med. Oncol. & Tumor Pharmacother. 1, 263–267 (1984). https://doi.org/10.1007/BF02934533

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02934533

Key words

Navigation